Magnetic resonance imaging of cartilage glycosaminoglycan: Basic principles, imaging technique, and clinical applications

Journal of Orthopaedic Research

Volumn 26, Issue 3, 2008, Pages 281-291

  Gray, Martha L ^a,b,c   Burstein, Deborah ^a,b   Kim, Young Jo ^d   Maroudas, Alice ^e  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c USA   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Arthritis; dGEMRIC; Glycosaminoglycan; MRI; Sodium

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE; GADOTERIDOL; GLYCOSAMINOGLYCAN; SODIUM 22; A73025; CONTRAST MEDIUM; DIAGNOSTIC AGENT; SODIUM; UNCLASSIFIED DRUG;

ARTICULAR CARTILAGE; CONTRAST ENHANCEMENT; HUMAN; IMAGING SYSTEM; IN VITRO STUDY; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; AWARDS AND PRIZES; BIOLOGICAL MODEL; CHEMISTRY; ELECTROCHEMISTRY; METABOLISM; METHODOLOGY; OSMOLARITY; OSTEOARTHRITIS; TISSUE DISTRIBUTION;

AWARDS AND PRIZES; CARTILAGE, ARTICULAR; CONTRAST MEDIA; ELECTROCHEMISTRY; GADOLINIUM DTPA; GLYCOSAMINOGLYCANS; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; OSMOLAR CONCENTRATION; OSTEOARTHRITIS; SODIUM; TISSUE DISTRIBUTION;

EID: 40949137022     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20482     Document Type: Review

References (38)

1. Maroudas A. 1979. Physicochemical properties of articular cartilage. In: Freeman M, editor. Adult articular cartilage 2nd edition. London: Pitman Medical; pp 215-290.
2. Eisenberg SR, Grodzinsky AJ. 1985. Swelling of articular cartilage and other connective tissues: electromechano-chemical forces. J Orthop Res 3:148-159.
3. Frank EH, Grodzinsky AJ, Koob TJ, et al. 1987. Streaming potentials: a sensitive index of enzymatic degradation in articular cartilage. J Orthop Res 5:497-508.
4. Freeman M. 1979. Adult articular cartilage, 2nd edition. London: Pitman Medical.
5. Maroudas A, Bayliss MT, Venn MF. 1980. Further studies on the composition of human femoral head cartilage. Ann Rheum Dis 39:514-523.
6. Maroudas A, Venn M. 1977. Chemical composition and swelling of normal and osteoarthrotic femoral head cartilage. II. Swelling. Ann Rheum Dis 36:399-406.
7. Ficat C, Maroudas A. 1975. Cartilage of the patella. Topographical variation of glycosaminoglycan content in normal and fibrillated tissue. Ann Rheum Dis 34:515-519.
8. Maroudas A, Evans H, Almeida L. 1973. Cartilage of the hip joint. Topographical variation of glycosaminoglycan content in normal and fibrillated tissue. Ann Rheum Dis 32:1-9.
9. Lesperance LM, Gray ML, Burstein D. 1992. Determination of fixed charge density in cartilage using nuclear magnetic resonance. J Orthop Res 10:1-13.
10. Jelicks LA, Paul PK, O'Byrne E, et al. 1993. Hydrogen-1, sodium-23, and carbon-13 MR spectroscopy of cartilage degradation in vitro. J Magn Reson Imaging 3:565-568.
11. Bashir A. 1995. Sodium NMR relaxation parameters in cartilage: implications for MR imaging [SM] Cambridge: Massachusetts Institute of Technology.
12. Insko EK, Reddy R, Leigh JS. 1997. High resolution, short echo time sodium imaging of articular cartilage. J Magn Reson Imaging 7:1056-1059.
13. Shapiro EM, Borthakur A, Dandora R, et al. 2000. Sodium visibility and quantitation in intact bovine articular cartilage using high field (23)Na MRI and MRS. J Magn Reson 142:24-31.
14. Bashir A, Gray ML, Burstein D. 1996. Gd-DTPA2- as a measure of cartilage degradation. Magn Reson Med 36: 665-673.
15. Bashir A, Gray ML, Boutin RD, et al. 1997. Glycosaminoglycan in articular cartilage: in vivo assessment with delayed Gd(DTPA)(2-)-enhanced MR imaging. Radiology 205:551-558.
16. Allen RG, Burstein D, Gray ML. 1999. Monitoring glycosaminoglycan replenishment in cartilage explants with gadolinium-enhanced magnetic resonance imaging. J Orthop Res 17:430-436.
17. Trattnig S, Mlynarik V, Breitenseher M, et al. 1999. MRI visualization of proteoglycan depletion in articular cartilage via intravenous administration of Gd-DTPA. Magn Reson Imaging 17:577-583.
18. Bashir A, Gray ML, Hartke J, et al. 1999. Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI. Magn Reson Med 41:857-865.
19. Burstein D, Bashir A, Gray ML. 2000. MRI techniques in early stages of cartilage disease. Invest Radiol 35:622-638.
20. Nieminen MT, Rieppo J, Silvennoinen J, et al. 2002. Spatial assessment of articular cartilage proteoglycans with Gd-DTPA-enhanced T1 imaging. Magn Reson Med 48:640-648.
21. Henkelman RM, Stanisz GJ, Menezes N, et al. 2002. Can MTR be used to assess cartilage in the presence of Gd-DTPA2-? Magn Reson Med 48:1081-1084.
22. Gillis A, Gray M, Burstein D. 2002. Relaxivity and diffusion of gadolinium agents in cartilage. Magn Reson Med 48:1068-1071.
23. Burstein D, Velyvis J, Scott KT, et al. 2001. Protocol issues for delayed Gd(DTPA)(2-)-enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage. Magn Reson Med 45:36-41.
24. Tiderius C, Hori M, Williams A, et al. 2006. dGEMRIC as a function of BMI. Osteoarthritis Cartilage 14:1091-1097.
25. Tiderius C, Jessel R, Kim Y-J, et al. 2007. Hip dGEMRIC in asymptomatic volunteers and patients with early osteoarthritis: the influence of timing after contrast injection. Magn Reson Imaging 57:803-805.
26. Williams A, Oppenheimer RA, Gray ML, et al. 2003. Differential recovery of glycosaminoglycan after IL-1-induced degradation of bovine articular cartilage depends on degree of degradation. Arthritis Res Ther 5:R97-R105.
27. Tiderius CJ, Svensson J, Leander P, et al. 2004. dGEMRIC (delayed gadolinium-enhanced MRI of cartilage) indicates adaptive capacity of human knee cartilage. Magn Reson Med 51:286-290.
28. Roos EM, Dahlberg L. 2005. Positive effects of moderate exercise on glycosaminoglycan content in knee cartilage: a four-month, randomized, controlled trial in patients at risk of osteoarthritis. Arthritis Rheum 52:3507-3514.
29. Williams A, Gillis A, McKenzie C, et al. 2004. Glycosaminoglycan distribution in cartilage as determined by delayed gadolinium-enhanced MRI of cartilage (dGEMRIC): potential clinical applications. AJR Am J Roentgenol 182:167-172.
30. Tiderius CJ, Olsson LE, Nyquist F, et al. 2005. Cartilage glycosaminoglycan loss in the acute phase after an anterior cruciate ligament injury: delayed gadolinium-enhanced magnetic resonance imaging of cartilage and synovial fluid analysis. Arthritis Rheum 52:120-127.
31. Young AA, Stanwell P, Williams A, et al. 2005. Glycosaminoglycan content of knee cartilage following posterior cruciate ligament rupture demonstrated by delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC). A case report. J Bone Joint Surg [Am] 87: 2763-2767.
32. Kim YJ, Jaramillo D, Millis MB, et al. 2003. Assessment of early osteoarthritis in hip dysplasia with delayed gadolinium-enhanced magnetic resonance imaging of cartilage. J Bone Joint Surg [Am] 85:1987-1992.
33. Minoda Y, Kadowaki T, Kim M. 2006. Total hip arthro-plasty of dysplastic hip after previous Chiari pelvic osteotomy. Arch Orthop Trauma Surg 126:394-100.
34. Cunningham T, Jessel R, Zurakowski D, et al. 2006. Delayed gadolinium-enhanced magnetic resonance imaging of cartilage to predict early failure of Bernese periacetabular osteotomy for hip dysplasia. J Bone Joint Surg [Am] 88:1540-1548.
35. Samosky JT, Burstein D, Eric Grimson W, et al. 2005. Spatially-localized correlation of dGEMRIC-measured GAG distribution and mechanical stiffness in the human tibial plateau. J Orthop Res 23:93-101.
36. Baldassarri M, Goodwin JS, Farley ML, et al. 2007. Relationship between cartilage stiffness and GAG content: correlation and prediction. J Orthop Res 25:904-912.
37. Tiderius CJ, Olsson LE, Leander P, et al. 2003. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis. Magn Reson Med 49:488-492.
38. Maroudas A, Thomas H. 1970. A simple physicochemical micromethod for determining fixed anionic groups in connective tissue. Biochim Biophys Acta 215:214-216.